Frequency of imaging in patients receiving rituximab maintenanceFrequency of imaging in patients receiving rituximab maintenance
Editor's comments
Routine surveillance imaging is receiving considerable attention in all corners of oncology because of concerns regarding costs, but both faculty and most of the MO surveyed do use this modality. Dr Kahl’s rationale is that he wants to avoid the expense and toxicity of treatment in patients with asymptomatic disease progression who are not benefitting from it. |